BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 1310637)

  • 21. [The relation between p53 mutations and tumor invasiveness of human hepatocellular carcinoma].
    Qin L; Tang Z; Liu K
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):405-8. PubMed ID: 8697987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P53 gene of chang-liver cells (Atcc-Ccl13) exposed to aflatoxin B1 (Afb): the effect of lysine on mutation at codon 249 of exon 7.
    Uwaifo O
    Afr J Med Med Sci; 1999; 28(1-2):71-5. PubMed ID: 12953991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutagenesis of ras proto-oncogenes in rat liver tumors induced by vinyl chloride.
    Froment O; Boivin S; Barbin A; Bancel B; Trepo C; Marion MJ
    Cancer Res; 1994 Oct; 54(20):5340-5. PubMed ID: 7923162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aflatoxin and p53 abnormality in duck hepatocellular carcinoma.
    Imazeki F; Yokosuka O; Ohto M; Omata M
    J Gastroenterol Hepatol; 1995; 10(6):646-9. PubMed ID: 8580407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation of p53 gene in hepatocellular carcinoma in Taiwan.
    Sheu JC; Huang GT; Lee PH; Chung JC; Chou HC; Lai MY; Wang JT; Lee HS; Shih LN; Yang PM
    Cancer Res; 1992 Nov; 52(21):6098-100. PubMed ID: 1327523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
    Yamada Y; Yoshida T; Hayashi K; Sekiya T; Yokota J; Hirohashi S; Nakatani K; Nakano H; Sugimura T; Terada M
    Cancer Res; 1991 Nov; 51(21):5800-5. PubMed ID: 1933850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
    Yakicier MC; Legoix P; Vaury C; Gressin L; Tubacher E; Capron F; Bayer J; Degott C; Balabaud C; Zucman-Rossi J
    Oncogene; 2001 Aug; 20(37):5232-8. PubMed ID: 11526514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human p53 gene mutated at position 249 per se is not sufficient to immortalize human liver cells.
    Schleger C; Becker R; Oesch F; Steinberg P
    Hepatology; 1999 Mar; 29(3):834-8. PubMed ID: 10051487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T
    Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 gene mutation spectrum in hepatocellular carcinoma.
    Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
    Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sequence alterations in p53 gene of hepatocellular carcinoma from high aflatoxin risk area in Guangxi].
    Deng Z; Pan L; Ma Y
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):18-21. PubMed ID: 10743047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection.
    Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Co-inactivation of the p53 and RB genes in human hepato cellular carcinoma].
    Murakami Y
    Nihon Rinsho; 1993 Feb; 51(2):375-9. PubMed ID: 8096551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The p53 mutation spectrum in hepatocellular carcinoma from Guangxi, China : role of chronic hepatitis B virus infection and aflatoxin B1 exposure.
    Qi LN; Bai T; Chen ZS; Wu FX; Chen YY; De Xiang B; Peng T; Han ZG; Li LQ
    Liver Int; 2015 Mar; 35(3):999-1009. PubMed ID: 24461059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Universal presence of HBVx gene and its close association with hotspot mutation of p53 gene in hepatocellular carcinoma of prevalent area in China].
    Zhang F; Zhu Y; Sun Z
    Zhonghua Zhong Liu Za Zhi; 1998 Jan; 20(1):18-21. PubMed ID: 10921048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of ras gene mutations in rainbow trout liver tumors initiated by aflatoxin B1.
    Chang YJ; Mathews C; Mangold K; Marien K; Hendricks J; Bailey G
    Mol Carcinog; 1991; 4(2):112-9. PubMed ID: 1645972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines.
    Hsu IC; Tokiwa T; Bennett W; Metcalf RA; Welsh JA; Sun T; Harris CC
    Carcinogenesis; 1993 May; 14(5):987-92. PubMed ID: 8389256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.